ALKBH5 and breast cancer: In addition, MTTL3 (Han, et al., 2019), ALKBH5 (Yu, et al., 2021), m6A (Gu, et al., 2019), IGF2BP3 (Huang et al., 2020c), and FTO (Tao, et al., 2021) levels are closely related to prognosis in BC patients.